Medicaid fuels US coverage of Novo, Lilly weight-loss drugs
State Medicaid programs for low-income families are the single biggest source of coverage, giving 31.6 million people access to Novo Nordisk's Wegovy or Eli Lilly's Zepbound, according to the AXIACI ...
Novo Nordisk reportedly launches Wegovy in China
Novo Nordisk (NVO) has reportedly launched its popular weight-loss drug Wegovy in China ahead of a rival drug by Eli Lilly ...
Weight loss drugs are more likely to be covered on government-funded insurance than on ...
New data shows that government-funded health insurance plans in the United States provide the majority of coverage for ...
Medicaid dominates coverage of Novo, Lilly weight-loss drugs
State Medicaid programs for low-income families are the single biggest source of coverage, giving 31.6 million people access ...
Exclusive-Medicaid Fuels US Coverage of Novo, Lilly Weight-Loss Drugs
State Medicaid programs for low-income families are the single biggest source of coverage, giving 31.6 million people access ...